in response to BSF-1 and/or PMA was determined as previously described using the fluorescent calcium-binding dye Quin 2 (30) .
Results
BSF-1 Acts on Highly Purified T Cells. To investigate the activity of BSF-1 on T cells, mesenteric lymph node cells were purified by an extensive procedure involving two rounds of passage over nylon wool, treatment with anti-la antibodies and complement, and depletion of IgM-bearing cells by panning on antiIgM-coated dishes . The resultant cells were then centrifuged on a discontinuous Percoll density gradient to obtain small cells . These were then stained with a mixture of fluoresceinated anti-L3T4 and Lyt-2 antibodies . Fluorescent cells were obtained by electronic cell sorting.
These highly purified small T cells showed a striking response to BSF-1 plus PMA, yielding incorporation of [3H]thymidine comparable to that observed in response to PMA plus the calcium ionophore A23187 (Table IA) . Neither BSF-1 nor PMA alone caused any detectable DNA synthesis. It should be noted that many conventional T cell stimulants, such as Con A, fail to stimulate T cells purified to this degree . Indeed, purified T cells developed very meager responses to Con A plus PMA (Table IA) .
The possibility that the costimulatory activity of the purified BSF-1 preparation might be due to contamination with IL-2 was addressed by examining the inhibitory capacity of monoclonal anti-BSF-1 and anti-IL-2 antibodies . Small BALB/c lymph node T cells were purified by passage over nylon wool treatment with anti-la antibodies and complement and centrifugation on a discontinuous Percoll density gradient . The response of these cells to BSF-1 plus PMA was completely inhibited by the monoclonal anti-BSF-1 antibody 11 B11 but was not affected either by the monoclonal anti-IL-2 antibody S4B6 .1 or by the monoclonal anti-DNP antibody 50C1 (Table IB) . These results indicate that the costimulatory activity of purified BSF-1 was a property of BSF-1 itself. In other experiments, PC 61 (31), a monoclonal rat IgGI anti-IL-2 receptor antibody failed to inhibit responses of T cells to purified BSF-1 and PMA (data not shown) . These results provided further support for the conclusion that it was BSF-1 itself, and not a putative IL-2 contaminant, which was responsible for the stimulation. Furthermore, PC 61 provides a class-matched control for 11 B 11 , which is also a rat IgG 1 .
Although the T cells used in these experiments were very extensively purified, it is possible that the small number of B cells that might remain contributed to this response, possibly by becoming efficient accessory cells as a result of stimulation by BSF-1 . We reasoned that if B cells were essential for the T cell responses to BSF-1 plus PMA, the addition of resting B cells to a highly purified T cell population might cause striking enhancement of its response . As shown in Table  I C, addition of purified B cells in amounts far in excess of the number of B cells that might possibly remain in the T cell population had no effect on the response to BSF-1 plus PMA. These experiments provide strong evidence that the BSF-1 effect is mediated by direct action on T cells.
The response of T cells to BSF-1 plus PMA was dependent on the BSF-1 concentration used . Maximal responses were obtained with 10-30 U/ml ( Fig . 1 ) (A) Highly purified T cells respond to BSF-1 plus PMA. BALB/c lymph node cells were purified by two passes over nylon wool, lysis with anti-la + C, and panning to deplete IgM+ cells. The remaining cells were then subjected to Percoll gradient centrifugation ; the small resting T cells banding at the interface between 66-70% Percoll were retained . These cells were then stained with fluoresceinated anti-L3T4 and anti-Lyt-2 and fluorescent cells obtained by electronic cell sorting. Sorted cells were cultured in 96-well flat-bottom plates at 2.5 X 10' cells/well .
['H]Thymidine was added at 48 h and the cells were harvested at 64 h of culture.
(B) Small T cells were prepared from mesenteric lymph nodes by passage over nylon wool, cytolysis with anti-la and C, and Percoll density gradient centrifugation . T cells were incubated at 2.5 X 10' cells/well with medium or BSF-1 plus PMA (I ng/ml) in the presence of ascitic fluid containing the monoclonal rat antibodies 111311 (anti-BSF-1), S4B6 . BSF-1 and PMA Stimulates Both L3T4' and Lyt-2+ Cells in a Density-independent Manner . To gain further insight regarding the possible role of cellular interactions in the response of T cells to BSF-1 and PMA, we examined the density dependence of this response . Purified small T cells were cultured at densities from 7 .8 X 10 2 cells/well to 2.5 X 104 cells/well . Over this range the T cell response to BSF-1 plus PMA was essentially density independent (Fig. 2) . The slope of the line relating the log of [sH]thymidine incorporation to the log of the number of cells cultured was 0.96 ± 0 .12, with a correlation coefficient (r2) of 0.97. Even at the lowest density (7 .8 X 10 2 cells/well), BSF-1 plus PMA caused a significant stimulation of T cells over the response to medium, BSF-1 alone, or PMA alone. This result strongly suggests that the T cell response to BSF-1 plus PMA does not depend on accessory cells, since the interaction of two or more cell types should be expected to yield a line with a log cell number/log response slope >1 .0. Indeed, the T cells used in this experiment had been purified to an extent that the actual number of non-T cells in populations cultured at the lowest density (7 .8 X 102 cells/well) was very small, probably <20 .
In the experiment shown in Fig. 2 , right, purified T cells treated with anti-Lyt-2 and C (L3T4+) or with anti-L3T4 and C (Lyt-2 +) were cultured at various densities with BSF-I plus PMA. For both populations, the slope relating the log cell number and the log response approached 1 . Lyt-2+ cells responded approximately threefold more vigorously than L3T4+ cells. It is very unlikely that the response of the L3T4 + cells could be due to residual Lyt-2+ T cells, because this (Fig. 3) . Thereafter, the yield of living cells increased with a doubling time of^-24 h, reaching 7.6 X 10' cells/well on day 5 . The yield of living cells from cultures containing PMA plus A23187 was essentially the same as that from cultures containing BSF-1 plus PMA. Cultures containing medium alone showed progressive cell death over the duration of the culture, reaching 0.4 X 10' cells/well on day 5. PMA accelerated the rate of cell loss . Strikingly, cultures treated with BSF-1 alone maintained good viability over the duration of the culture, falling from 2 .5 X 10' cells/well at the outset to 1 .5 X 10' at day 5. Since these cells incorporated essentially no thymidine over this period, we conclude that treatment of resting T cells with BSF-1 alone maintained their viability. In turn, this indicates that BSF-1 acts on resting T cells. This viability-promoting activity of BSF-1 does not appear to be associated with any gross activation of the T cells. Over a 48-h period, T cells cultured with BSF-1 alone remain small. Fig. 4 shows results of a 24-h culture of T cells. Purified small T cells cultured in medium alone or in BSF-1 are a homogeneous population of small cells at 24 h (median cell volume, 113-120 Am') . PMA causes a small increase in the volume of these cells, but BSF-1 plus PMA causes a DURATION OF CULTURE (Days) FIGURE 3 . T cell responses to PMA + BSF-1 and to BSF-1 . Dense BALB/c T cells were cultured at 2.5 X 10' cells/well in medium alone (RPMI), BSF-1 (30 U/ml), PMA (1 ng/ml), PMA plus BSF-1, or PMA plus A23187 (100 ng/ml). Yield of viable cells (left) and uptake of [sH]thymidine during a 4-h pulse (right) are shown . considerably more striking increase ; such T cells have a median volume of 196 Am'. What is particularly interesting is that the entire size histogram of the T cell population treated with BSF-1 plus PMA is displaced in comparison to that of the T cell population treated with PMA alone, implying that virtually all resting T cells are responsive to costimulation by these agents .
Further demonstration that BSF-1 plus PMA acts on a significant proportion of T cells was obtained by measuring the percent of T cells in the S, G2, and M phases of the cell cycle at 48 h after stimulation with BSF-1 plus PMA (Table  11) . At this time, 58% of the surviving cells are in S, G2, or M, emphasizing that the action of BSF-1 plus PMA is not confined to a small subpopulation of T cells.
BSF-I Is Required Both in the Early and Late Phases of the Initial Response of T Cells. BSF-1 has been shown to act on resting B cells to enhance expression of class 11 MHC molecules (2, 3) and to prepare these cells to enter S phase more promptly in response to high concentrations of anti-Ig antibodies or to LPS (16) (17) (18) . We therefore tested the time requirements of BSF-1 and of PMA in the response of resting T cells. T cells were cultured for 24 h in medium, BSF-1, PMA, or BSF-1 plus PMA. To the cells precultured in medium for 24 h, medium, PMA, BSF-1, or BSF-1 plus PMA were added. These cells failed to respond to PMA or to BSF-1 . They did respond to PMA plus BSF-1 (Fig. 5) , but only at 48 h of secondary culture, indicating that the initial cohort of cells responding to CELL VOLUME (Rel . Units) FIGURE 4. BSF-1 plus PMA causes T cell enlargement . Dense BALB/c T cells were cultured for 24 h at 2.5 x 105 cells/ml/well in medium (RPMI), BSF-1 (30 U/ml), PMA (10 ng/ml), BSF-1 plus PMA, or PMA plus A23187 (100 ng/ml) . Cell volume was measured at the termination of culture. Small resting T cells were prepared by two rounds of passage over nylon wool, treatment with anti-la plus C, and Percoll density centrifugation .
These cells were cultured at 2.5 x 105 cells/ml for 48 h with various stimulants . Colcemid was added 20 h after initiation of assay. Cells were pelleted at 10 6 cells/tube and resuspended in hypotonic PI . Suspended nucei were analyzed for DNA content after 24 h at 4°C.
BSF-1 plus PMA does not enter S phase until after 24 h. By contrast, cells precultured in BSF-1 plus PMA and then cultured with the same stimulants during the secondary culture showed a striking response at 24 h and an even greater response at 48 h. We then asked whether preculture in either BSF-1 or in PMA would prepare cells to respond at 24 h of secondary culture in BSF-1 plus PMA . As shown in Fig. 5 , neither BSF-1 or PMA preculture accelerated the response of these cells to PMA plus BSF-1, indicating that both agents were required from the outset of the culture. Thus, BSF-1 is required early in the first round of T cell proliferation to PMA plus BSF-1 . BSF-1 is also required in the latter phases of the T cell response to BSF-1 plus 5 . Both BSF-1 and PMA are required early in culture. Dense BALB/c T cells were precultured for 24 h at 2.5 X 10' cells/well, in medium (four sets of replicates), BSF-1 (30 U/ml) (two sets of replicates), PMA (1 ng/ml) (two sets of replicates) or BSF-1 plus PMA. Medium, BSF-1, PMA, or BSF-1 plus PMA was added to cells precultured in medium ; medium or PMA was added to cells precultured in BSF-1 ; medium or BSF-1 was added to cells precultured in PMA; medium was added to cells precultured in BSF-1 plus PMA. In each of these cultures, the additive(s) present in the preculture was also present in the secondary culture because the cells were not washed . Cells were pulsed for 4 h with [sH]thymidine before harvest at 24 or 48 h of secondary culture.
PMA . Removal of BSF-1 from cultures after 24 h inhibits entry into S phase. T cells were precultured for 24 h with medium alone or with PMA plus BSF-1 . After 24 h, these cells were washed and recultured for 24 h with medium, PMA, BSF-1, or PMA plus BSF-1 . These cells were then incubated with ['H]thymidine for 16 h before harvest . Cells pretreated for 24 h with PMA plus BSF-1 do not take up [sH]thymidine in secondary culture with medium alone, or with PMA (Table 111) . By contrast, they show striking responses to BSF-1 plus PMA and to BSF-1 alone. This result indicates the need for BSF-1 at times beyond the first 24 h of culture. The fact that PMA did not have to be added in the second culture does not establish a lack of requirement for PMA at that point in the response, since PMA is poorly removed by washing. Nonetheless, because prolonged PMA treatment leads to a depletion of cellular protein kinase C in many systems (32) , it is quite possible that PMA, even if present, exerts relatively little action after 24 h. Cells pretreated in medium alone make a modest response to BSF-1 plus PMA in secondary culture, but this is far less than that of cells precultured in PMA plus BSF-1, indicating that the response measured in the latter case is not simply a response commencing at the onset of the secondary culture. These results suggest that BSF-1 is required both in the early and later portions of the G, phase of the first cell cycle in the response of resting T cells to BSF-1 and PMA. Neither IL-1, IL-3, or IFN-7 synergizes with BSF-1 or with PMA in the stimulation of resting T cells, nor did these agents inhibit the response to BSF-1 plus PMA (Table IV) . IL-2 also failed to synergize with BSF-1 . However, IL-2 showed striking synergy with PMA, and this response was additive with the BSF-1 plus PMA response . or PMA (10 ng/ml) followed by BSF-1 . Con A (10 wg/ml) was added 6 or 5 min after BSF-1 .
[Ca2']; was calculated based on fluorescence at 492 nM .
ionophores A23187 (Table I and in resting T cells treated with BSF-1 alone or with BSF-1 plus PMA and found no elevation (Fig. 6 ) . By contrast, Con A increases [Ca 211, in both untreated and PMA-treated cells, but shows poor synergy with PMA for T cell entry into S phase (Table I ) . This strongly suggests that BSF-1 costimulatory effects are not mediated in a manner entirely analogous to those of the calcium ionophore.
In this communication, we show that the T cell-derived lymphokine BSF-1 synergizes with PMA in the stimulation of resting normal T cells. This response can be obtained with highly purified populations of small T cells cultured at very low cell density (<1,000 cells/well). Furthermore, the slope relating the log of cell number cultured and the log of the response is^-1 . Both results strongly suggest that the costimulatory activity of BSF-I plus PMA does not depend upon an accessory cell . Thus, BSF-1 and PMA, acting together, are sufficient for the activation of resting T cells.
Essentially all T cells are responsive to BSF-1 plus PMA, as indicated by the finding that virtually all cells treated with this combination of stimulants have enlarged by 24 h. A substantial fraction of the stimulated cells enter S phase. Lyt-2+ cells incorporate more [sH]thymidine in response to BSF-1 plus PMA than do L3T4+ cells, but we have not established that the fraction of Lyt-2+ T cells that enter S phase in response to BSF-1 plus PMA exceeds the fraction of L3T4+ cells that mount such a response .
T cell activation has been proposed to involve the elevation of [Ca2+]i and the stimulation of protein kinase C (PKC)-catalyzed protein phosphorylation (33, 34) . PMA and calcium ionophore stimulation of T cells is in keeping with this concept, since PMA activates PKC (35, 36) and calcium ionophores elevate (38, 39) . However, an important difference here is that the LPS response in B cells also appears to be independent of PKC (Mizuguchi and Paul, unpublished observations), whereas BSF-1 effects on T cells depend upon PMA and, presumably, upon protein phosphorylation catalyzed by PKC. Thus, the capacity of BSF-1 plus PMA to stimulate efficient, accessory cell-independent activation of resting T cells raises questions about how accessory cells act in T cell stimulation and about the central role of [Ca2+ ] ; elevation in the responses. One possible explanation for this result is that the response to PMA plus A23187 requires both an induction of sensitivity to lymphokine, such as IL-2 or BSF-1, and the stimulation of lymphokine production . In the response to BSF-1 plus PMA and to IL-2 plus PMA (discussed below), it is possible that only sensitivity to lymphokine need be induced, since BSF-1 or IL-2 is supplied exogenously. This leads to the conclusion that induction of sensitivity to lymphokine may be due to the action of PKC (or possibly through the action of another cellular target of PMA) without any requirement for increase in [Ca2+] ;. An important issue is to identify the natural ligand(s) that replaces PMA in its synergy with BSF-1 and with IL-2 . Although receptor crosslinking agents are obvious candidates, their role in replacing PMA has not been established.
In the course of this work, we also noted that PMA plus IL-2 caused resting T cells to become activated and to enter S phase. Like BSF-1, IL-2 is required during the first 24 h of the response (Hu-Li and Paul, unpublished observations) suggesting that it acts on Go or, more likely, early G, T cells. One possible mode of stimulation by this combination of agents would be the induction by PMA of a small number of IL-2 receptors and the upregulation of receptor number through the action of IL-2 (40) . Such cells might then be stimulated to enter S phase by the binding of IL-2 to the heightened number of receptors present in late G, .
BSF-1 has been shown to act directly on resting B cells (2, 3, (16) (17) (18) . We show here that BSF-1 can act on resting T cells. Thus, the addition of BSF-1 to resting T cells causes striking increases in cell viability detectable by 2 d and persisting for periods of 5 d or more without any evidence of cell division . In addition, BSF-1 is required early in the costimulation of T cells; delaying the addition of BSF-1 by 24 h to cells cultured with PMA delays entry into S phase by 24 h. This strikingly parallels the action of BSF-1 on B cells, where delaying its addition to B cells cultured with anti-IgM delays their entry into S phase (18) .
These results indicate that BSF-1 acts on resting T cells and thus raise the question of how BSF-1 may regulate T cell growth . Two major possibilities exist.
BSF-1 may function by acting on resting T cells, together with PMA, to induce IL-2 receptor expression and IL-2 production. This could be restated to say that BSF-1 plus PMA jointly act as a competence factor for resting (G o) T cells and that IL-2 acts as in late G, to stimulate entry into S phase (i.e., as a progression factor). We have already proposed a similar model for the action of BSF-1 on B cells, where we suggest that BSF-1 and anti-IgM jointly act as a Go and/or early G, competence factor (18) . Recently, BSF-1 has been shown to enhance the responses of some mast cell lines to IL-3 (14) . Peschel, Paul, Ohara, and Green (manuscript submitted for publication) have shown that BSF-1 synergizes with recombinant erythropoietin and with IL-1 for the formation of megakaryocytic colonies in soft agar, with erythropoietin for the formation of erythroid colonies, and with granulocyte colony-stimulating factor for the formation of granulocytic colonies. Based on these observations, we suggest that BSF-1 may act as a competence factor (or a competence cofactor) for virtually all hematopoietic lineage cells.
A second possibility is that BSF-1 may act both as a lymphocyte activating factor and as a progression factor . According to this concept, rather than stimulating T cell responses by inducing IL-2 receptor expression and IL-2 production, BSF-1 causes resting T cells to enter S phase by acting with PMA to activate these cells and to render them sensitive to the growth stimulating activity of BSF-1 itself. BSF-I would thus act as a cocompetence factor and as a progression factor. Indeed, it has been shown that many T cell lines fail to secrete IL-2 but do produce BSF-1 (41) . The growth of one such line, D10, in response to antigen and antigen-presenting cells is inhibited by monoclonal antibodies to BSF-1, but not by antibody to the IL-2 receptor (42) . Similarly, Fitch and colleagues (43) have described a cloned T cell line the growth of which was stimulated by antigen and antigen-presenting cells and did not require the addition of IL-2 . Nevertheless, this line did not secrete detectable IL-2; IL-2 mRNA was not found by hybridization to dot blots, and antibody to the IL-2 receptor did not block its responses to antigen and antigen-presenting cells. These results suggest that lymphokines other than IL-2 can act as T cell progression factors. Indeed, finding that an anti-IL-2 antibody (S4B6 .1) fails to inhibit responses to BSF-1 plus PMA suggests that IL-2 is not required for all growth in response to BSF-1 plus PMA.
In our opinion, understanding the mode of action of BSF-1 on T cells and relating it to that of IL-2 is a goal of considerable importance . Direct studies aimed at this issue are now in progress in our laboratory .
Finally, we note that IFN-y does not block the actions of BSF-1 plus PMA on resting T cells. IFN-y has been shown to be a powerful inhibitor of the action of BSF-1 on resting B cells, blocking both preparation to enter S phase (44) and induction of class II molecules (45) . This result indicates that the inhibitory effect of IFN-y is cell type-specific and not general.
Summary
Resting T cells proliferate in response to B cell stimulatory factor 1 (BSF-1 ; interleukin 4) plus phorbol myristate acetate (PMA). This response is obtained with highly purified T cells and is density independent, suggesting that accessory cells are not required. Both L3T4+ and Lyt-2+ T cells respond to BSF-1 plus PMA .
Although BSF-1 alone does not cause T cell proliferation, it maintains the viability of small, dense T cells, indicating that it acts on resting T cells.
Furthermore, BSF-1 is required early in the proliferative response of resting T cells to BSF-1 plus PMA, further supporting the concept that it acts on Go or early G, cells. However, BSF-1 is also needed late in the first round of division of T cells stimulated with BSF-1 plus PMA . Removing BSF-1 at 24 h of stimulation prevents entry into S phase . These results indicate that BSF-1 is involved in both the induction of competence and in the progression phases of T cell division.
